Mèra Stein

973 total citations
25 papers, 642 citations indexed

About

Mèra Stein is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Mèra Stein has authored 25 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Mèra Stein's work include Coronary Interventions and Diagnostics (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Cardiac electrophysiology and arrhythmias (9 papers). Mèra Stein is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Cardiac electrophysiology and arrhythmias (9 papers). Mèra Stein collaborates with scholars based in Netherlands, Belgium and United Kingdom. Mèra Stein's co-authors include Harold V.M. van Rijen, Jacques M.T. de Bakker, Toon A.B. van Veen, Maartje Noorman, John A. Jansen, Richard N.W. Hauer, M. Boulaksil, Marc A. Vos, Roel van der Nagel and Markus A. Engelen and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Mèra Stein

24 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mèra Stein Netherlands 11 525 345 95 62 37 25 642
Rob F. Wiegerinck Netherlands 11 399 0.8× 268 0.8× 72 0.8× 65 1.0× 13 0.4× 17 527
Katherine M. Holzem United States 13 383 0.7× 311 0.9× 92 1.0× 83 1.3× 16 0.4× 20 567
Tae‐Joon Cha South Korea 12 1.1k 2.1× 379 1.1× 65 0.7× 60 1.0× 30 0.8× 33 1.2k
Paul Simpson United States 6 222 0.4× 199 0.6× 51 0.5× 31 0.5× 26 0.7× 11 359
Patric Glynn United States 11 403 0.8× 339 1.0× 33 0.3× 69 1.1× 14 0.4× 13 542
Masanori Hirose Japan 13 315 0.6× 180 0.5× 48 0.5× 48 0.8× 25 0.7× 33 471
Silvia Suffredini Italy 11 452 0.9× 255 0.7× 29 0.3× 61 1.0× 15 0.4× 17 581
Stacie Kroboth United States 12 420 0.8× 403 1.2× 65 0.7× 62 1.0× 16 0.4× 21 676
Edward P. Cheng United States 10 340 0.6× 310 0.9× 58 0.6× 123 2.0× 4 0.1× 15 571
Wolfgang Schöls Germany 10 437 0.8× 261 0.8× 36 0.4× 67 1.1× 41 1.1× 36 514

Countries citing papers authored by Mèra Stein

Since Specialization
Citations

This map shows the geographic impact of Mèra Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mèra Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mèra Stein more than expected).

Fields of papers citing papers by Mèra Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mèra Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mèra Stein. The network helps show where Mèra Stein may publish in the future.

Co-authorship network of co-authors of Mèra Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Mèra Stein. A scholar is included among the top collaborators of Mèra Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mèra Stein. Mèra Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gho, B. C. G., Mustafa İlhan, Leo Veenstra, et al.. (2023). Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention. Netherlands Heart Journal. 31(11). 426–433. 1 indexed citations
3.
Stella, Pieter R., Mèra Stein, Peter Frambach, et al.. (2022). High bleeding risk in patients undergoing percutaneous coronary intervention with drug-eluting stent implantation: ReCre8 subanalysis. SHILAP Revista de lepidopterología. 24. 100227–100227. 1 indexed citations
4.
Voskuil, Michiel, Mèra Stein, Peter Frambach, et al.. (2021). 3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent. JACC: Cardiovascular Interventions. 14(22). 2477–2486. 10 indexed citations
5.
Gho, B. C. G., Mèra Stein, Mustafa İlhan, et al.. (2021). Importance of confirming the underlying diagnosis in patients with myocardial infarction and non-obstructive coronary arteries (MINOCA): a single-centre retrospective cohort study. BMC Cardiovascular Disorders. 21(1). 357–357. 3 indexed citations
6.
Voskuil, Michiel, Mèra Stein, Peter Frambach, et al.. (2021). Clinical outcomes after permanent polymer or polymer‐free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy. Catheterization and Cardiovascular Interventions. 99(2). 366–372. 4 indexed citations
7.
Damen, Johanna AAG, Stefan Koudstaal, Mèra Stein, et al.. (2020). Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the ReCre8 trial. Netherlands Heart Journal. 29(4). 201–214. 3 indexed citations
9.
Pisters, Ron, Mustafa İlhan, Leo Veenstra, et al.. (2018). Instantaneous wave-free ratio and fractional flow reserve in clinical practice. Netherlands Heart Journal. 26(7-8). 385–392. 10 indexed citations
10.
Stein, Mèra, Michiel Voskuil, Peter Frambach, et al.. (2018). Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent. Circulation. 139(1). 67–77. 24 indexed citations
11.
Benedetto, Daniela, Adriaan O. Kraaijeveld, Michiel Voskuil, et al.. (2017). Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents: A single-center registry. Cardiovascular revascularization medicine. 19(5). 521–525. 3 indexed citations
12.
Boulaksil, M., Marti F.A. Bierhuizen, Markus A. Engelen, et al.. (2016). Spatial Heterogeneity of Cx43 is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias during Compensated Cardiac Hypertrophy in Rats. Frontiers in Cardiovascular Medicine. 3. 5–5. 14 indexed citations
13.
14.
Stein, Mèra, Toon A.B. van Veen, Richard N.W. Hauer, Jacques M.T. de Bakker, & Harold V.M. van Rijen. (2011). A 50% Reduction of Excitability but Not of Intercellular Coupling Affects Conduction Velocity Restitution and Activation Delay in the Mouse Heart. PLoS ONE. 6(6). e20310–e20310. 36 indexed citations
15.
Boulaksil, M., Markus A. Engelen, Mèra Stein, et al.. (2010). Heterogeneous Connexin43 Distribution in Heart Failure is Associated with Dispersed Conduction and Enhanced Susceptibility to Ventricular Arrhythmias. European Journal of Heart Failure. 12(9). 913–921. 54 indexed citations
16.
Stein, Mèra, Toon A.B. van Veen, Carol Ann Remme, et al.. (2009). Combined reduction of intercellular coupling and membrane excitability differentially affects transverse and longitudinal cardiac conduction. Cardiovascular Research. 83(1). 52–60. 46 indexed citations
17.
Stein, Mèra, M. Boulaksil, Markus A. Engelen, et al.. (2006). Conduction reserve and arrhythmias.. PubMed. 14(3). 113–116. 10 indexed citations
18.
Bakker, Jacques M.T. de, Mèra Stein, & Harold V.M. van Rijen. (2005). Three-dimensional anatomic structure as substrate for ventricular tachycardia/ventricular fibrillation. Heart Rhythm. 2(7). 777–779. 39 indexed citations
19.
Veen, Toon A.B. van, Mèra Stein, Anne Royer, et al.. (2005). Impaired Impulse Propagation in Scn5a -Knockout Mice. Circulation. 112(13). 1927–1935. 127 indexed citations
20.
Rosendorff, Clive, et al.. (1976). Noradrenaline Sensitivity of an Isolated Perfused Artery: Effects of Normal and Hypertensive Plasma. Clinical Science. 51(s3). 469s–471s. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026